Promotion of mental health and prevention of depression and anxiety. Mental and Behavioural Disorders
Conditions
Interventions
The study is a multi-center community unblinded interventional study. Two communities will be identified in five countries, purposively (allocation of intervention is purposively). These are the inter
Sponsors
Directorate-General Joint Research Centre
Eligibility
Sex/Gender
All
Age
15 Years to 24 Years
Inclusion criteria
Inclusion criteria: 1. Aged 15-24 years old 2. Proficient in the national language 3. Informed consent
Exclusion criteria
Exclusion criteria: Not meeting the participant inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measure as of 29/05/2025: Resilience is measured using the Child Youth Resilience Measure (CYRM-R), Executive Functioning is measured using the Adult Executive Function Inventory (ADEXI), and Emotional regulation is measured using the Emotion Regulation Questionnaire (ERQ) at baseline (T1), mid-intervention (T2), end of intervention (T3), and (T0) follow-up _____ Previous primary outcome measure: Mental health is measured using the Brief Resilience Scale (BRS) at baseline (T1), mid-intervention (T2), end of intervention (T3), and (T0) follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 29/05/2025: The following secondary outcome measures are assessed at baseline (T0), mid-intervention (T1), end of intervention (T2), and follow-up (T3): 1. Depression measured using the Patient Health Questionnaire-9 (PHQ-9) 2. Anxiety measured using the Generalized Anxiety Disorder-7 (GAD-7) 3. Stress disorder measured using the International Trauma Questionnaire (ITQ) 4. Substance use measured using the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST – LITE) 5. Gratitude measured using the The Gratitude Questionnaire-6, (GQ-6) 6. Optimism measured using the Revised Life Orientation Test (LOT-R) 7. Well-being measured using the Wellbeing Scale _____ Previous secondary outcome measures: The following secondary outcome measures are assessed at baseline (T0), mid-intervention (T1), end of intervention (T2), and follow-up (T3): 1. Depression measured using the Patient Health Questionnaire-9 for teens (PHQ-A) 2. Anxiety measured using the Generalized Anxiety Disorder-7 (GAD-7) 3. Stress disorder measured using the International Trauma Questionnaire (ITQ) 4. Substance use measured using the International Trauma Questionnaire (ITQ) and the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST – LITE) 5. Executive functioning measured using the Teenage/Adult Executive Function Inventory 6. Emotional control measured using the Emotion Regulation Questionnaire for Children and Adolescents (ERQ-CA) 7. Resilience measured using the Child Youth Resilience Measure (CYRM-R) 8. Gratitude measured using the The Gratitude Questionnaire-6, (GQ-6) 9. Optimism measured using the Revised Life Orientation Test (LOT-R) 10. Well-being measured using the Wellbeing Scale | — |
Countries
Belgium, Germany, Moldova, Poland, Portugal
Contacts
Public ContactJutta Lindert
Outcome results
None listed